Protopanaxatriol, a novel PPARγ antagonist from Panax ginseng, alleviates steatosis in mice
Open Access
- 9 December 2014
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 4 (1) , 7375
Abstract
Obesity is prevalent worldwide, and is highly associated with metabolic disorders, such as insulin resistance, hyperlipidemia and steatosis. Ginseng has been used as food and traditional herbal medicine for the treatment of various metabolic diseases. However, the molecular mechanisms how ginseng and its components participate in the regulation of lipogenesis are still largely unclear. Here, we identified that protopanaxatriol (PPT), a major ginseng constituent, inhibited rosiglitazone-supported adipocyte differentiation of 3T3-L1 cells by repressing the expression of lipogenesis-related gene expression. In high-fat diet-induced obesity (DIO) mice, PPT reduced body weight and serum lipid levels, improved insulin resistance, as well as morphology and lipid accumulation, particular macrovesicular steatosis, in the livers. These effects were confirmed with genetically obese ob/ob mice. A reporter gene assay showed that PPT specifically inhibited the transactivity of PPARγ, but not PPAR α, β/δ and LXR α, β. TR-FRET assay revealed that PPT was specifically bound to PPARγ LBD, which was further confirmed by the molecular docking study. Our data demonstrate that PPT is a novel PPARγ antagonist. The inhibition of PPARγ activity could be a promising therapy for obesity and steatosis. Our findings shed new light on the mechanism of ginseng in the treatment of metabolic syndrome.Keywords
This publication has 47 references indexed in Scilit:
- Anti-obesity effects of black ginseng extract in high fat diet-fed miceJournal of Ginseng Research, 2013
- Fat Depots, Free Fatty Acids, and DyslipidemiaNutrients, 2013
- The Effects of Periconceptional Risk Factor Exposure and Micronutrient Supplementation on Birth Defects in Shaanxi Province in Western ChinaPLOS ONE, 2012
- Rhein Reduces Fat Weight indb/dbMouse and Prevents Diet-Induced Obesity in C57Bl/6 Mouse through the Inhibition of PPARγSignalingPPAR Research, 2012
- Anti‐Hyperglycemic Effect of Fermented Ginseng in Type 2 Diabetes Mellitus Mouse ModelPhytotherapy Research, 2012
- Ginsenoside-Rg1 Protects the Liver against Exhaustive Exercise-Induced Oxidative Stress in RatsEvidence-Based Complementary and Alternative Medicine, 2012
- Effects of rosiglitazone on the liver histology and mitochondrial function in ob/ob mice†Hepatology, 2007
- Increased expression of PPARγ in high fat diet-induced liver steatosis in miceBiochemical and Biophysical Research Communications, 2005
- Diabetic KKAy mice exhibit increased hepatic PPARγ1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinedionesJournal of Hepatology, 2001
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973